SMI 9'035 0.2%  Dow 18'133 -0.5%  Nikkei 18'827 0.2%  Euro 1.0726 0.4% 
SPI 8'943 0.2%  EStoxx50 3'604 0.2%  Gold 1'217 0.2%  Dollar 0.9564 0.2% 
DAX 11'437 0.3%  FTSE100 6'969 0.3%  Öl 62.0 -0.1%  Pfund 1.4741 0.2% 

Biomarin Pharmaceutical Aktie [Valor: 729021 / ISIN: US09061G1013]

Analysen zu Biomarin Pharmaceutical Inc.

19.12.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
11.12.14 Biomarin Pharmaceutical Buy UBS AG
25.11.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
24.10.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
06.11.12 Biomarin Pharmaceutical outperform RBC Capital Markets
03.09.12 Biomarin Pharmaceutical outperform RBC Capital Markets
28.08.12 Biomarin Pharmaceutical hold Deutsche Bank Securities
23.07.12 Biomarin Pharmaceutical outperform RBC Capital Markets
22.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
01.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
17.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
13.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
12.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
08.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
07.12.11 Biomarin Pharmaceutical buy Jefferies & Company Inc.
29.09.11 Biomarin Pharmaceutical buy Deutsche Bank Securities
25.10.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
17.08.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
16.04.10 Biomarin Pharmaceutical kaufen Der Aktionär
29.10.09 Biomarin Pharmaceutical outperform Credit Suisse Group
22.10.09 Biomarin Pharmaceutical buy Citigroup Corp.
19.10.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
08.10.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
03.08.09 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
31.07.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
27.07.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
31.03.09 Biomarin Pharmaceutical market weight Thomas Weisel Partners LLC
27.03.09 Biomarin Pharmaceutical neutral Piper Jaffray & Co.
12.03.09 Biomarin Pharmaceutical outperform Leerink Swann LLC
12.03.09 Biomarin Pharmaceutical buy FTN Midwest Securities Corp.
24.02.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
23.02.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
19.02.09 Biomarin Pharmaceutical neutral Credit Suisse Group
19.02.09 Biomarin Pharmaceutical market perform Wachovia Securities, LLC
19.02.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
19.02.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
09.01.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
15.12.08 Biomarin Pharmaceutical neutral Credit Suisse Group
26.11.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
24.11.08 Biomarin Pharmaceutical buy Citigroup Corp.
30.10.08 Biomarin Pharmaceutical neutral Credit Suisse Group
30.10.08 Biomarin Pharmaceutical buy UBS AG
29.10.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.09.08 Biomarin Pharmaceutical outperform William Blair
27.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
22.08.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
22.08.08 Biomarin Pharmaceutical market outperform Rodman & Renshaw, LLC
22.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
02.07.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.06.08 Biomarin Pharmaceutical hold Citigroup Corp.
Seite: 1 | 2

Anmeldung notwendig

Benutzername (E-Mail):
Passwort:
 
Anmelden
 

Um diese Funktionalität nutzen zu können, müssen Sie sich anmelden.
Falls Sie noch kein Benutzerkonto bei finanzen.ch besitzen, können Sie sich hier kostenlos registrieren.

Eintrag hinzufügen

Aktuelle Aktienanalysen
11:52 Dril-Quip Mkt Perform FBR Capital
11:49 La Jolla Pharmaceutical Buy Chardan Capital Markets
11:48 Cracker Barrel Old Country Store Hold Miller Tabak
11:44 PTC Therapeutics Buy ROTH Capital Partners, LLC
11:43 Iconix Brand Group Buy ROTH Capital Partners, LLC
11:39 Hudson Pacific Properties Neutral Mizuho
11:37 CST Brands Buy Mizuho
10:41 Airbus Group (ehemals EADS) overweight Barclays Capital
09:02 K+S buy Société Générale Group S.A. (SG)
08:04 AXA buy Société Générale Group S.A. (SG)
07:25 RWE Outperform Bernstein Research
27.02.15 Iberdrola overweight JP Morgan Chase & Co.
27.02.15 GDF SUEZ Neutral JP Morgan Chase & Co.
27.02.15 Anheuser-Busch InBev overweight JP Morgan Chase & Co.
27.02.15 British American Tobacco overweight JP Morgan Chase & Co.
27.02.15 Standard Chartered Neutral JP Morgan Chase & Co.
27.02.15 Helmerich & Payne Buy Argus Research Company
27.02.15 Goodyear Tire & Rubber Buy Argus Research Company
27.02.15 3D Systems Neutral UBS AG
27.02.15 Crane Buy UBS AG
27.02.15 Allianz buy Commerzbank AG
27.02.15 GERRY WEBER International buy Deutsche Bank AG
27.02.15 Ensco Neutral UBS AG
27.02.15 Fielmann Hold Deutsche Bank AG
27.02.15 H & E Equipment Services Neutral UBS AG
27.02.15 HSN Buy UBS AG
27.02.15 Infoblox Neutral UBS AG
27.02.15 Kohl`s Buy UBS AG
27.02.15 Life Time Fitness Neutral UBS AG
27.02.15 Ross Stores Neutral UBS AG
27.02.15 Splunk Buy UBS AG
27.02.15 Triton PCS Buy UBS AG
27.02.15 Bank of America Neutral UBS AG
27.02.15 Airbus Group (ehemals EADS) Hold S&P Capital IQ
27.02.15 Lloyds Banking Group buy S&P Capital IQ
27.02.15 Chegg Outperform BMO Capital Markets
27.02.15 Rosetta Resources Market Perform BMO Capital Markets
27.02.15 QEP Resources Market Perform BMO Capital Markets
27.02.15 Credit Suisse Outperform BMO Capital Markets
27.02.15 SeaWorld Entertainment Outperform FBR Capital
27.02.15 3D Systems Hold Deutsche Bank AG
27.02.15 ON Semiconductor Buy Deutsche Bank AG
27.02.15 Infoblox Buy Deutsche Bank AG
27.02.15 Ross Stores Buy Deutsche Bank AG
27.02.15 Hercules Offshore Sell Deutsche Bank AG
27.02.15 Magellan Health Services Equal weight Barclays Capital
27.02.15 Walter Investment Management Underweight Barclays Capital
27.02.15 Splunk Equal weight Barclays Capital
27.02.15 L Brands overweight Barclays Capital
27.02.15 Catamaran Equal weight Barclays Capital